Home/ News & Events
Calling ESID Juniors!
Are you interested in developing personalized CRISPR correction strategies for inborn errors of immunity?
The University of Oslo & Oslo University Hospital are thrilled to announce two researcher openings, both for recent PhD graduates and experienced scientists in the CRISPR gene therapy group under the supervision of group leader Emma Haapaniemi (MD PhD, Group Leader at NCMM).
Both positions are based at the Centre for Molecular Medicine Norway (NCMM), an EMBL (European Molecular Biology Laboratories) partnership institute. Since its establishment in 2008, the NCMM has altogether 11 research groups.
Further information and the application links are available on the Haapaniemilab website.
Apply before Thursday 30th November 2023
Apply to volunteer before Thursday, 9th November 2023.
Prof. Siobhán Burns, the chair of the ESID Clinical Working Party (CWP), is looking for two ESID Juniors who would be interested in working with the CWP over the next 3-6 months to make a priority list for future ESID Clinical Guidelines!
This is a fantastic opportunity for members of the Juniors to actively contribute to the mission of the CWP and the wider ESID community to improve the awareness, diagnosis, treatment and understanding of immune system disorders. Through the establishment of these guidelines, the selected Juniors will directly contribute to the development of a clinical best practice strategy which promotes scientific excellence, and which sets the standard for our speciality.
Involvement in this initiative will also be of enormous benefit to any ambitious researcher, boosting their professional profiles amongst the specialist network affiliated with the CWP.
Successful applicants to this initiative would oversee the following tasks:
1. Complete a literature search for existing guidelines/ best practice articles in IEI (using a software such as Rayyan) and present this to the CWP in a CWP meeting.
2. Develop an on-line survey that the CWP can send to the ESID community to explore what guidelines people want.
3. Analyse the results of the survey and present this back to the CWP.
4. Work with the CWP to develop a priority list.
The two selected applicants would be tasked with completing the first draft of a literature review by Monday, 11th December which is when the next CWP meeting takes place. This would enable the selected volunteers to allocate enough time towards completing the initial literature review throughout November.
Additional support and assistance for the software training will be personally provided by Siobhán Burns,
To apply for this exciting opportunity, please send your CV and a brief email outlining why you would like to do this and whether you have any experience in literature searches or developing surveys to by COB Thursday, 9th November.
Applicants will be informed of the outcome by Monday, 13th November.
For any questions about the future Guidelines, or about the application process, please contact Siobhán Burns directly.
Apply by 3 December
The IMMERGE project, a Doctoral Network funded by Marie Skłodowska-Curie (MSCA) Actions of the European Commission, coordinated by the Josep Carreras Institute has opened a call to recruit highly motivated PhD candidates to join their network. The call will be closed on December 3rd, 2023.
This is a fantastic opportunity for PhD candidates looking to pursue research in the fields of immunology, genetics, epigenetics, proteomics, single cell omics, bioinformatics, or gene correction in an international environment. Applications can be made via this link: https://immergeproject.eu/apply-now/
Detailed information concerning the application and selection process of the 12 doctoral positions can be found on the program’s website: https://immergeproject.eu
Extended applications deadline for the 2024 IAPIDS Advanced Clinical Immunology Training and Career Building!
Apply Today for the 2024 IAPIDS Training Course!
Dear ESID Junior Members,
We are pleased to inform you that the October 2023 Call for ESID Fellowships is now open! Please, visit the Fellowships page for more information.
The ESID Administrative office
We are pleased to announce on behalf of the Transatlantic Gene Therapy Consortium that the 13th Stem Cell Clonality and Genome Stability Retreat will take place on October 23th, 2023 in Brussels, Belgium.
The program of the event is available here .
We are pleased to share information about the "KID_interferon" project, provided by Lorenzo Lodi.
Brief rationale of the project:
Monogenic type I interferonopathies (T1I) (like COPA syndrome (COPA), STING-associated vasculopathy with onset in infancy (SAVI) or some monogenic lupus) may display renal involvement. These entities are characterized by a systemic upregulation of type I interferons (IFN-I) which is central to the disease pathogenesis. However, a clear documentation of IFN-I upregulation at tissue level is still lacking. Indeed, this would be crucial to understand the selective organ involvement encountered in these diseases. The demonstration of tissue IFN-I upregulation can be performed applying human myxovirus resistance protein 1 (MxA) immunostaining to renal biopsies. While this characterization has been assessed in a few patients with T1I-related kidney diseases, it has never been performed in SAVI, COPA and several others T1I.
Here you can find more details about the project.
We are excited to announce that the 22nd Biennial Meeting of ESID will be held in 2026 in Maastricht, The Netherlands!
It is with great sadness that we learned of the tragic and death of our colleague, Oksana Leontieva, a pediatric hematologist from Ukraine and a victim of a recent missile strike in Kyiv ( https://www.telegraph.co.uk/world-news/2022/10/11/ukraine-russia-war-oksana-leontyeva-killed-air-strikes-kyiv/).
We at ESID offer our deepest condolences to her family, friends and colleagues of the National Pediatric Ohmatdyt Hospital.
We take this somber moment to send our thoughts and prayers in the memory of all other fellow humans who needlessly perished as a result of the current war.